SUPERNUS PHARMACEUTICALS, INC. (SUPN) has 10 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 14, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 14, 2026 filed Aug. 12, 2026 | Khattar Jack A. President, CEO | — | +17,207 | — | No | |
|
|
||||||
| Aug. 14, 2026 filed Aug. 12, 2026 | Rubin Jonathan SVP, Chief Medical Officer | — | +387 | — | No | |
|
|
||||||
| Aug. 14, 2026 filed Aug. 12, 2026 | Bhatt Padmanabh P. Sr. VP of IP, CSO | — | +1,342 | — | No | |
|
|
||||||
| Aug. 14, 2026 filed Aug. 12, 2026 | DEC TIMOTHY C Senior Vice-President & CFO | — | +646 | — | No | |
|
|
||||||
| Aug. 14, 2026 filed Aug. 12, 2026 | Mottola Frank SVP, Chief Tech. Ops. Officer | — | +853 | — | No | |
|
|
||||||
Showing the 5 most recent of 10 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free